Skip to main content
. 2020 May-Jun;36(4):765–769. doi: 10.12669/pjms.36.4.1531

Table-I.

Baseline and clinical parameters of subjects with duration of T1DM.

Parameters Group-A Group-B P-value Overall
n 99 84 - 183
Age(years) 12.3±5.2 18.7±9.0 <0.0001 15.5±7.8
Gender
Female 42(42.4%) 45(53.6%) 0.132 87(47.5%)
Male 57(57.6%) 39(46.4%) 96(52.5%)
BMI (kg/m2) 16.51±3.3 21.57±4.3 <0.0001 18.88±4.57
Duration of DM (years) 0.64±0.6 7.65±5.5 <0.0001 3.83±5.1
Family history of T1DM
No 98(99%) 76(90.48%) 0.02 174(95.1%)
Yes 1(1%) 8(9.52%) 9(4.9%)
Family history of T2DM
No 72(72.7%) 63(75%) 0.857 135(73.8%)
Yes 27(27.3%) 21(25%) 48(26.2%)
HbA1c (%) 11.12±2.31 10.42±1.45 0.756 10.77±1.88
C-peptide (ng/dl) 1.91±1.53 1.82±1.01 0.984 1.87±1.32
Diabetic Ketoacidosis (DKA)
No 78(78.8%) 66(78.6) 0.884 144(78.7%)
Yes 21(21.2%) 18(21.4%) 39(21.3%)

Data presents as mean ± SD or n (%), P<0.05 considered to be statistically significant.